Stockscreener 앱 받기
7.08
7.89%
-0.71
Akari Therapeutics Plc Adr 주식(AKTX)의 최신 뉴스
Akari Therapeutics Plc Sponsored ADR Revenue Breakdown – LS:A4270Y - TradingView
Stock Ratings | Morgan Stanley raised its target price for Intel (INTC) to $75; Maxim Group initiated coverage on Rein Therapeutics (RNTX) with a target price of $4, representing a potential gain of 373.93%. - Sahm
Akari Therapeutics CEO Explains Why Growing Industry Demand for Next-Generation ADC Payloads Positions the Company at the Center of a Major Oncology Opportunity - Sahm
Akari Therapeutics partners with Whitehawk on dual payload study By Investing.com - Investing.com South Africa
Akari Therapeutics partners with Whitehawk on dual payload study - Investing.com
Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics - Sahm
Price to earnings forward of Akari Therapeutics Plc Sponsored ADR – TRADEGATE:CLA1 - TradingView
Form S-3/A Akari Therapeutics PLC For: 10 July By Investing.com - Investing.com South Africa
Akari Therapeutics (NASDAQ: AKTX) files to register 5.99M ADSs from May 2026 private placement - Stock Titan
Akari Therapeutics (NASDAQ: AKTX) adds private‑placement warrants and purchase agreement exhibits - Stock Titan
Akari Therapeutics Appoints Former AACR President and Renowned Oncology Drug Development Leader, Patricia LoRusso, D.O., to Scientific Advisory Board - Finviz
Akari Therapeutics appoints Patricia LoRusso to advisory board - Investing.com
Akari Therapeutics appoints Patricia LoRusso to advisory board By Investing.com - Investing.com India
Akari Therapeutics (NASDAQ: AKTX) registers 5,999,999 ADSs, 80,000-shares each - Stock Titan
Akari Therapeutics completes $8.3m capital raise in Q2 - Investing.com
Akari Therapeutics completes $8.3m capital raise in Q2 By Investing.com - Investing.com India
AKTXAkari Therapeutics Plc ADR Options - Finviz
Form S-1/A Akari Therapeutics PLC For: 26 June By Investing.com - Investing.com South Africa
White Lion resale of 2.5M Akari (NASDAQ: AKTX) ADSs under $25M equity deal - Stock Titan
AKTX Forecast — Price Target — Prediction for 2027 - TradingView
Akari Therapeutics Plc Sponsored ADR Actuals & Estimates (NASDAQ:AKTX) - TradingView
CLA1 Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Akari Therapeutics PLC For: 25 June By Investing.com - Investing.com India
Akari Therapeutics (AKTX) CEO granted stock options tied to ADS and financings - Stock Titan
Akari Therapeutics (AKTX) interim CFO granted new ADS awards - Stock Titan
A4270Y Forecast — Price Target — Prediction for 2027 - TradingView
AKTX Options Chain — NASDAQ:AKTX - TradingView
symbol__ Stock Quote Price and Forecast - CNN
Akari Therapeutics PLC (FRA:CLA1) Valuation - GuruFocus
VNET Group, Akari Therapeutics and other big stocks moving lower in Tuesday's pre-market session - MSN
Akari Therapeutics Q1 2026 Earnings: EPS Misses Estimates but Stock Rises 5.7% on Pipeline HopeSurprise Factor Analysis - dars.gov.et
Large share issuance and governance votes ahead at Akari (NASDAQ: AKTX) 2026 AGM - Stock Titan
Akari Therapeutics partners with WuXi XDC on ADC development - Investing.com
Diluted earnings per share (diluted EPS) of Akari Therapeutics Plc Sponsored ADR – TRADEGATE:CLA1 - TradingView
12 Health Care Stocks Moving In Friday's Intraday Session - Sahm
Which stocks have an unusual volume on Thursday? - ChartMill
VNET Group, Akari Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Akari Therapeutics Soars as KRAS ADC Data Triggers Rerating - timothysykes.com
Akari Therapeutics (AKTX) AGM June 30, 2026 — equity authorizations, warrants/ADSs - Stock Titan
Akari Therapeutics (NASDAQ: AKTX) sets $5.5M ADS and warrant private placement - Stock Titan
Keep an eye on the top gainers and losers in Friday's session. - ChartMill
Friday's session: gap up and gap down stocks - ChartMill
Discover the top movers in Friday's pre-market session. - ChartMill
Akari Therapeutics Announces $5.5 Million Private Placement Offering - Sahm
Akari Therapeutics stock rockets 50% higher on KRAS combination data - Investing.com
Akari Therapeutics prices $5.5 million private placement By Investing.com - Investing.com South Africa
Akari Therapeutics prices $5.5 million private placement - Investing.com
Why Akari Therapeutics Stock Is Surging On Thursday? - Sahm
12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm
Akari Therapeutics secures European patent for ADC payload - Investing.com
0.28%
자본화:
|
볼륨(24시간):